Bulletin of Experimental Treatments for AIDS (BETA), published by the San Francisco AIDS Foundation, is one of the most comprehensive HIV treatment publications, with hundreds of in-depth articles.

BETA is published quarterly by the San Francisco AIDS Foundation.

BETA
Main page

Subscribe (free)

Contact Us
beta@sfaf.org

April 1999 Table of Contents

Features

HAART Attack: Metabolic Disorders During Long-Term Antiretroviral Therapy
Current Challenges to HIV Research
Volunteering for Clinical Trials

Departments

BETA News Briefs
Drug Watch
-- New Anti-HIV Drugs in Development
-- Calanolide A: A Natural Non-Nucleoside Reverse Transcriptase Inhibitor

Women and HIV
-- Recent News about Women and HIV

Conference Coverage
-- Selected Highlights from the 6th Conference on Retroviruses and Opportunistic Infections
Glossary

Notice

The statements and opinions in BETA are published as an educational resource only, and do not imply recommendation or endorsement by BETA or the San Francisco AIDS Foundation. Always consult a physician before taking any drug or changing a drug regimen.

Contributors to this issue:

  • Harvey S. Bartnof, MD
  • Ethan David
  • Leslie Hanna
  • Liz Highleyman
  • David Townley

Scientific Advisory Committee:

  • Kirsten Balano, PharmD
  • Harvey S. Bartnof, MD
  • Gregory Pauxtis, MD
  • Mary Romeyn, MD

Page last updated 1 June 1999


About AIDS | Treatment | Prevention | Policy | About SFAF | Take Action | Donate
Espaņol | Search | Site Map | Feedback | Email Updates | Home (sfaf.org)